NEUROLOGY 1985;35:219
© 1985 American Academy of Neurology
Epidemiology of brain tumors
The national survey of intracranial neoplasms
A. Earl Walker, MD,
Morton Robins, MSPH and
Frederic D. Weinfeld, EdD
Department of Neurosurgery (Dr. Walker), University of New Mexico School of Medicine, Albuquerque, NM; Westat Research (Mr. Robins), Rockville; and Section of Surveys and Demographic Studies (Dr. Weinfeld), National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, MD.
A national survey, based on a probability sample of patients admitted to short-term hospitals in the United States during 1973 to 1974 with a discharge diagnosis of an intracranial neoplasm, was conducted in 157 hospitals. The annual incidence was estimated at 17,000 for primary intracranial neoplasms and 17,400 for secondary intracranial neoplasms—8.2 and 8.3 per 100,000 US population, respectively. Rates of primary intracranial neoplasms increased steadily with advancing age. The age-adjusted rates were higher among men than among women (8.5 versus 7.9 per 100,000). However, although men were more susceptible to gliomas and neuronomas, incidence rates for meningiomas and pituitary adenomas were higher among women.
Address correspondence and reprint requests to Dr. Weinfeld, Chief, Section on Surveys and Demographic Studies, National Institute of Neurological and Communicative Disorders and Stroke, 7550 Wisconsin Avenue, Bethesda, MD 20205.
Supported by the National Institute of Neurological and Communicative Disorders and Stroke under Contract No. NO-1-NS-4–2336 with Westat Research, who condurted the national survey.
Accepted for publication June 8, 1984.
This article has been cited by other articles:
|
|
|
|
 
M. Winterstein, M. W. Munter, I. Burkholder, M. Essig, H.-U. Kauczor, and M.-A. Weber
Partially Resected Gliomas: Diagnostic Performance of Fluid-attenuated Inversion Recovery MR Imaging for Detection of Progression
Radiology,
March 1, 2010;
254(3):
907 - 916.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Pisati, M. Belicchi, F. Acerbi, C. Marchesi, C. Giussani, M. Gavina, S. Javerzat, M. Hagedorn, G. Carrabba, V. Lucini, et al.
Effect of Human Skin-Derived Stem Cells on Vessel Architecture, Tumor Growth, and Tumor Invasion in Brain Tumor Animal Models
Cancer Res.,
April 1, 2007;
67(7):
3054 - 3063.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Akabani, D. A. Reardon, R. E. Coleman, T. Z. Wong, S. D. Metzler, J. E. Bowsher, D. P. Barboriak, J. M. Provenzale, K. L. Greer, D. DeLong, et al.
Dosimetry and Radiographic Analysis of 131I-Labeled Anti-Tenascin 81C6 Murine Monoclonal Antibody in Newly Diagnosed Patients with Malignant Gliomas: A Phase II Study
J. Nucl. Med.,
June 1, 2005;
46(6):
1042 - 1051.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Nakamizo, F. Marini, T. Amano, A. Khan, M. Studeny, J. Gumin, J. Chen, S. Hentschel, G. Vecil, J. Dembinski, et al.
Human Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Cancer Res.,
April 15, 2005;
65(8):
3307 - 3318.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kirsch, P. Weigel, T. Pinzer, R. S. Carroll, P. McL. Black, H.-K. Schackert, and G. Schackert
Therapy of Hematogenous Melanoma Brain Metastases with Endostatin
Clin. Cancer Res.,
February 1, 2005;
11(3):
1259 - 1267.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Barnholtz-Sloan, A. E. Sloan, F. G. Davis, F. D. Vigneau, P. Lai, and R. E. Sawaya
Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System
J. Clin. Oncol.,
July 15, 2004;
22(14):
2865 - 2872.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. F. Lang, J. M. Bruner, G. N. Fuller, K. Aldape, M. D. Prados, S. Chang, M. S. Berger, M. W. McDermott, S. M. Kunwar, L. R. Junck, et al.
Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical Results
J. Clin. Oncol.,
July 1, 2003;
21(13):
2508 - 2518.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. F. Lang, M. R. Gilbert, V. K. Puduvalli, J. Weinberg, V. A. Levin, W.K. A. Yung, R. Sawaya, G. N. Fuller, and C. A. Conrad
Toward better early-phase brain tumor clinical trials: A reappraisal ofcurrent methods and proposals for future strategies
Neuro Oncology,
October 1, 2002;
4(4):
268 - 277.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. J. McCarthy, T. Surawicz, J. M. Bruner, C. Kruchko, and F. Davis
Consensus Conference on Brain Tumor Definition for Registration
Neuro Oncology,
April 1, 2002;
4(2):
134 - 145.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T. Shono, P. J. Tofilon, T. S. Schaefer, D. Parikh, T.-J. Liu, and F. F. Lang
Apoptosis Induced by Adenovirus-mediated p53 Gene Transfer in Human Glioma Correlates with Site-specific Phosphorylation
Cancer Res.,
February 1, 2002;
62(4):
1069 - 1076.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Bonnette, P. Puyo, C. Gabriel, R. Giudicelli, J.-F. Regnard, M. Riquet, and P.-Y. Brichon
Surgical Management of Non-small Cell Lung Cancer With Synchronous Brain Metastases
Chest,
May 1, 2001;
119(5):
1469 - 1475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. Rand, R. J. Kreitman, N. Patronas, F. Varricchio, I. Pastan, and R. K. Puri
Intratumoral Administration of Recombinant Circularly Permuted Interleukin-4-Pseudomonas Exotoxin in Patients with High-Grade Glioma
Clin. Cancer Res.,
June 1, 2000;
6(6):
2157 - 2165.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
B. K. MacDonald, O. C. Cockerell, J. W. A. S. Sander, and S. D. Shorvon
The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK
Brain,
April 1, 2000;
123(4):
665 - 676.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Graf, M. R. Jadus, J. C. Hiserodt, H. T. Wepsic, and G. A. Granger
Development of Systemic Immunity to Glioblastoma Multiforme Using Tumor Cells Genetically Engineered to Express the Membrane-Associated Isoform of Macrophage Colony-Stimulating Factor
J. Immunol.,
November 15, 1999;
163(10):
5544 - 5551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. S. Surawicz, B. J. McCarthy, V. Kupelian, P. J. Jukich, J. M. Bruner, F. G. Davis, and the collaborating registries of the Central Brain
Descriptive epidemiology of primary brain and CNS tumors: Results fromthe Central Brain Tumor Registry of the United States, 1990-1994
Neuro Oncology,
January 1, 1999;
1(1):
14 - 25.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. P. Merchut
Brain Metastases From Undiagnosed Systemic Neoplasms
Arch Intern Med,
May 1, 1989;
149(5):
1076 - 1080.
[Abstract]
[PDF]
|
|
|
|
